FASN and breast carcinoma: Oleuropein aglycone (OA, Fig 1) identified as the most in vitro potent EVOO phenolic against HER2-dependent breast cancer cell viability by selectively triggering high levels of apoptotic cell death and suppressing lipogenic enzyme fatty acid synthase expression [21, 22].